News

QuatRx Pharmaceuticals, a biopharmaceutical company, has completed enrollment in the company’s second pivotal Phase III clinical trial of Ophena, an advanced estrogen-free oral therapy currently in development for

Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm’s twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to

StemCells, a biotechnology company, has completed the acquisition of substantially all of the operating assets and liabilities of Stem Cell Sciences, an international R&D company, for 2.65 million

Using design input from physicians around the country, iMedica developed Transition to provide physicians with an alternative to a full-fledged electronic health record (EHR)/practice management system by streamlining

The stem cell face cream is to be sold wholesale to major cosmetic distributors worldwide; focusing on the US and EU. Stem Cell Therapy International will soon be

Plethora Solutions, a developer of drugs and medical devices for the diagnosis, treatment and management of urological disorders, has reported that, following a recent meeting with the FDA

Alzheimer’s Drug Discovery Foundation (ADDF) provided support for the development of novel tools for drug discovery applications, including cellular models of disease and biosensors that allow for sensitive

According to Sorin, the Esprit pacemaker, the latest family in the company’s pacemaker portfolio, is the world’s smallest pacemaker, at 8cc, with no compromise on longevity. Esprit includes

Teva’s generic Adderall XR capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD). In August 2006, Teva’s subsidiary Barr Pharmaceuticals entered into a licensing agreement